The White House, under pressure to contain a growing monkeypox outbreak, announced on Thursday that it was sending 1.8 million vaccine doses to jurisdictions that agree to use a new vaccine protocol.

The Biden administration didn't get any more monkeypox vaccine. It is trying to stretch the existing stockpile by promoting a different method of administration. Federal health officials say it's just as effective if you inject it into the skin.

The White House wants to encourage states and cities to use the so-called intradermal method for contraception. Those who have done so will be able to order more vaccine starting on Monday.

Robert J. Fenton Jr., the White House monkeypox response coordinators, told reporters on Thursday that more shots in arms is how we get under control.

New York City, the epicenter of the U.S. outbreak, has yet to switch to the new method of drug administration. Some scientists and activists are concerned about the vaccine's protocol.

The company expressed some reservations about the system in a letter to the health secretary of the president. The company said it had reached an agreement with a U.S.-based contract manufacturer to bottle doses of the vaccine, which will ease the current shortage.

Activists said that the better response would be to work with cities and states on a more flexible vaccine plan. Some shots would be given into the skin, most likely by major health centers that were equipped to do so, and some would be given in the more traditional way, by providers who weren't trained or equipped to switch.

Osmundson said that what they are doing is unscientific. It's not correct to pretend that 100 percent of the doses will be given within the body.

The founder of a patient advocacy group called Thursday's announcement about vaccine distribution a complete accounting trick. The new protocol could signal to people of color that they might be getting a lesser dose even though health officials have approved it.

When it becomes equitable, it will not be "We'll give you the dosage that everyone was getting prior", but "We'll give you the shorter doses".

Card 1 of 7

Monkeypox is what it is. The symptoms of monkeypox are not as severe as those ofpox. There was an outbreak in monkeys kept for research. Most of the people who have sex with men who have the virus are from Central and West Africa.

What does it do? The monkeypox virus can be spread by coughing or sneezing, or by touching items that have previously touched the rash, or by touching items that have not touched the rash. During and after birth, monkeypox can be transmitted from the mother to the fetus.

I'm afraid I might have a disease. I don't know what to do. You can't test for monkeypox if you only have flu symptoms. You can get a monkeypox test from an urgent care center or your primary care doctor. If you have to come in contact with other people for medical care, you should be isolated at home.

I live in the city. Is it possible to get the vaccine? Adult men who have sex with men and have had multiple sexual partners in the last 14 days are eligible for a vaccine in New York City. People with conditions that weaken the immune system or have a history of allergies are encouraged to get the vaccine. There is a website that people can use to book an appointment.

In order to have the treatments readily available, officials said they would distribute 50,000 doses of Tpoxx. Many patients were not given Tpoxx until more than a week after their symptoms began, because it was hard to get it.

Last week, after an article in The New York Times detailed the difficulties doctors and patients faced in acquiring the drug, Rep.

The nation has recorded more than 13,000 cases of monkeypox, an infectious disease that can be extremely painful, and has been spread primarily among men who have sex with men.

Upcoming events could fuel the next outbreak.

As students return to school, universities and colleges are preparing to deal with the monkeypox problem. Black Pride in Atlanta and Southern Decadence in New Orleans will take place over the weekend.

The organizers of Southern Decadence in New Orleans, one of the country's biggest Pride celebrations, canceled a free concert due to concerns about monkeypox.

Dr. Rochelle Walensky is the director of the Centers for Disease Control and Prevention. The government isn't trying to discourage people from attending gay life celebrations.

The events give people a chance to connect with their community and have fun. Public health messages and resources can be provided to populations that are hard to reach.

The New York Times reported earlier this month that the shortage of the Jynneos vaccine was due to the Department of Health and Human Services failing to ask for bulk stock of the vaccine to be bottled. The agreement with Grand River Aseptic Manufacturing would allow delivery of the product to the US while freeing up capacity for other countries.

Gay rights activists and state and local health officials have been critical of the administration's response to vaccinations.

The health commissioner in New York said in an interview on Thursday that more time was needed to train people in the method. He said that providers at community health organizations might be less likely to be trained in the method and that some people might be less willing to take the one-fifth dose.

Dr. Vasan thinks everyone is under pressure. Every jurisdiction feels like this is a fast switch. It was done in a short time. We are going to take our time and get this right, especially in the biggest, most complex city in the country, with the one of the most complex delivery systems in the country.

There isn't much information on whether Jynneos is safe or effective. Small studies show that the vaccine appears to produce an immune response similar to that of an older vaccine. There isn't much evidence to support the use of one fifth of Jynneos to prevent monkeypox.

One study did not show a decrease in efficacy, but it did show some side effects like swelling and redness. Dr. Peter Hotez, a vaccine expert at the Baylor School of Medicine in Houston, said he would have liked the government to do an additional pilot study on the benefits and drawbacks of injecting a vaccine into the skin.

To confirm the safety effects are not worse than we thought, we need to collect more data. He thought the approach to addressing the problem of supply was innovative.

The approach has been used to increase vaccine supply for other diseases. He said that in a public health emergency, officials must make recommendations based on what seems plausible from previous evidence and experience.

He said avoiding recommendations is a cop-out. Clinical trials can show how well a one-fifth dose would match up against the full dose.

The shortfall of vaccine doses forced the administration to move ahead with the trial, even though federal scientists had planned to start it in the fall.